JSCAX
Price
$18.06
Change
-$0.72 (-3.83%)
Updated
Dec 18 closing price
VSIAX
Price
$85.23
Change
-$3.35 (-3.78%)
Updated
Dec 18 closing price
Ad is loading...

JSCAX vs VSIAX

Header iconJSCAX vs VSIAX Comparison
Open Charts JSCAX vs VSIAXBanner chart's image
JHancock Small Cap Value A
Price$18.06
Change-$0.72 (-3.83%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Value Index Admiral
Price$85.23
Change-$3.35 (-3.78%)
VolumeN/A
CapitalizationN/A
JSCAX vs VSIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JSCAX vs. VSIAX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JSCAX is a Hold and VSIAX is a Hold.

FUNDAMENTALS
Fundamentals
VSIAX has more cash in the bank: 63B vs. JSCAX (564M). VSIAX pays higher dividends than JSCAX: VSIAX (2.01) vs JSCAX (0.39). JSCAX was incepted earlier than VSIAX: JSCAX (11 years) vs VSIAX (13 years). JSCAX is a more actively managed with annual turnover of: 49.00 vs. VSIAX (16.00). JSCAX has a lower initial minimum investment than VSIAX: JSCAX (1000) vs VSIAX (3000). VSIAX annual gain was more profitable for investors over the last year : 16.23 vs. JSCAX (0.78). VSIAX return over 5 years is better than : 52.83 vs. JSCAX (-11.49).
JSCAXVSIAXJSCAX / VSIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years13 years-
Gain YTD9.12315.03161%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets564M63B1%
Annual Yield % from dividends0.392.0119%
Returns for 1 year0.7816.235%
Returns for 3 years-12.9220.67-63%
Returns for 5 years-11.4952.83-22%
Returns for 10 years-5.14105.65-5%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALTO1.470.04
+2.80%
Alto Ingredients
ADXN7.80-0.05
-0.64%
Addex Therapeutics Ltd
DCOM33.96-0.84
-2.41%
Dime Community Bancshares
CAVA123.37-3.42
-2.70%
CAVA Group
EWTX30.17-2.52
-7.71%
Edgewise Therapeutics